AI in RCM has become commonplace, but adoption alone says little about whether the technology is improving performance. MGMA reported in June that nearly seven in 10 medical groups had added or expanded AI tools in the prior year, with revenue cycle among the areas seeing increased use. The more important question now is not whether AI is present. It is whether organizations are applying it to the right work and measuring the results that matter.

That distinction matters because discussions of AI in RCM often treat AI and automation as if they are interchangeable. They are not. Automation is highly effective when a process is repetitive, rules-based and predictable. AI can extend that capability by recognizing patterns, prioritizing activity, identifying risk and helping determine the next best action. Used together, the technologies can change how work moves through the revenue cycle. Used without a clear operational purpose, they can simply add another layer of complexity.

Automation and AI Are Not the Same Thing

Traditional automation follows defined instructions. It can move files, trigger communications, route work, update fields or complete other repeatable tasks without requiring an employee to perform every step manually. That remains valuable because revenue cycle operations contain a substantial amount of high-volume, transactional work.

AI becomes useful when the task depends on recognizing relationships across larger sets of information. Rather than following only a fixed sequence, an AI-enabled model can identify patterns in past outcomes, rank accounts by likelihood of a particular result, or recommend which action should occur next. That does not mean turning consequential decisions over to a model. Revenue cycle leaders interviewed by Becker’s have emphasized that AI is most effective when it supports human expertise, especially in areas such as work-queue prioritization, denial patterns and low-complexity tasks, while people remain responsible for strategy, interpretation, escalation and oversight.

The distinction is practical: automation can reduce unnecessary manual effort, while AI can help organizations decide where that effort should be directed. The value comes from matching the technology to the problem rather than applying the newest tool to every workflow.

Where AI Is Adding Value in Revenue Cycle Operations

The most useful applications of AI in RCM are generally tied to a defined operational question. Which accounts should receive attention first? Which communication channel is most likely to reach a patient? When is outreach most likely to be effective? What patterns in a conversation or account history may signal a need for a different approach?

At RevCycle, that principle is reflected in the way AI is being incorporated into patient engagement and collection strategy. Interaction history, digital engagement, payment behavior, voice data and other account characteristics can be used to support more precise segmentation and contact recommendations. Speech analytics adds another layer by evaluating call characteristics and patient interactions at scale. The technology is not replacing the person responsible for the interaction; it is helping provide better information about where attention may produce the greatest value.

The same progression is visible elsewhere in the industry. Becker’s recently highlighted how Grady Health System standardized its revenue cycle workflows before expanding robotic process automation and AI across key functions. The sequence is important. Technology becomes more useful when the underlying process is consistent enough for the organization to understand what the technology is actually improving.

Better Data Creates Better Decisions

AI performance is inseparable from the information available to the model. A single data point rarely explains how a patient will respond, why an account remains unresolved or which outreach strategy is most appropriate. The value comes from combining relevant signals and continually comparing recommendations with actual outcomes.

In patient financial engagement, those signals can include payment history, prior contacts, digital activity, account characteristics, channel response and information captured during voice interactions. A feedback loop then makes the outcome of each interaction useful to the next decision. A successful contact, an unanswered call, a payment, an email response or a change in account status becomes additional information rather than an isolated event.

This is also where data discipline becomes critical. Poor data quality, inconsistent workflows or unclear ownership can limit the usefulness of even sophisticated technology. MGMA’s guidance on AI governance reinforces the need for defined accountability as organizations adopt AI, particularly as models and vendor capabilities continue to change. Better technology does not eliminate the need for sound operating controls; it increases the importance of them.

Technology Should Strengthen the Human Revenue Cycle

The strongest use case for AI is not necessarily the one that removes the most people from a process. It is the one that improves how available expertise is used. Repetitive activity can be automated. Large volumes of information can be analyzed more quickly. Work can be prioritized with greater precision. That creates room for employees to concentrate on exceptions, complex account questions, patient communication, quality control and decisions that require context.

The workforce impact is already beginning to reflect that shift. MGMA found that most practices using AI had not redesigned roles outright, while organizations that had made changes generally described smaller, task-level adjustments. In revenue cycle and call-center functions, software is increasingly handling routine first-pass work while employees take the cases that are complex, low-confidence or patient-facing.

That balance matters in healthcare. Financial performance may be the objective of a revenue cycle operation, but the work frequently involves people navigating insurance questions, medical bills and financial decisions they may not fully understand. Technology can make those interactions more informed and efficient. It should not remove the accountability, judgment and communication that make them effective.

How to Measure AI’s Revenue Cycle Impact

The most important measurement decision should happen before an AI initiative begins: define the problem and establish the baseline. If a tool is intended to improve contact strategy, the organization should know its existing contact and conversion performance. If the objective is reducing manual work, current staff touches, handling time or processing time should be understood first. If the goal is financial, the relevant recovery, payment or cost metric should already be visible.

From there, the value of AI in RCM should be measured as closely as possible to the function the technology is intended to improve. Useful revenue cycle measures can include contact rates, payment conversion, average payment amount, liquidation or recovery rates, days in A/R, cost to collect, staff touches, handling time, digital deliverability and response rates, quality scores, complaints and patient-experience measures. The right KPI set will vary by use case, but it should connect operational activity to a meaningful downstream result.

Controlled comparisons can make that connection clearer. Champion-challenger testing, for example, allows an organization to compare an AI-informed strategy with an existing approach rather than assuming that performance changes were caused by the new technology. RevCycle uses champion-challenger measurement in evaluating AI-driven contact strategies. Separately, one recent primary bad-debt AI test group showed an early 11% increase in average payment size, providing another concrete performance signal to evaluate before broader expansion.

Measurement should also continue after implementation. AI models can change as new information enters the system, patient behavior changes and workflows evolve. A successful launch does not establish lasting value. Performance should be reviewed over time against the original baseline, operational KPIs and financial outcomes. That approach aligns with a broader point RevCycle noted after the 2026 HFMA Revenue Cycle Conference: the technology conversation is increasingly moving from what a tool can do to what measurable result it can deliver.

Closing Reflection

AI can expand what revenue cycle teams are able to see, prioritize and act on, while automation continues to remove friction from predictable work. Neither creates value simply by being deployed. The stronger standard is whether the technology solves a defined operational problem, supports the people responsible for the work and produces an improvement that can be measured.

As AI becomes more common across revenue cycle operations, that discipline will matter more, not less. The organizations that benefit most will be those that can distinguish capability from impact—and prove the difference in their own performance.